ADIPOQ and type 2 diabetes mellitus: Daily administration of LY2405319 to type 2 diabetes patients for 4 weeks significantly reduced triglycerides by about 45% and LDL-cholesterol by 20–30% from baseline, while increasing HDL-cholesterol by 15–20% and adiponectin by up to 80% (244).